Schedule 13D ownership disclosure
CYTOTHERAPEUTICS INC/DE
Security class unavailable
Event date: 2016-11-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 26.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-16-019251
- Form type
- SC 13D
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Dec 08, 2016
- Reporting period
- Nov 28, 2016
- Description
- Schedule 13D beneficial ownership